Miki Ohira
11PUBLICATIONS
54CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jan 21, 2026
Coexpression of MYCN and ALK Induces Neuroblastoma-Like Tumors From Human iPS Cell-Derived Cranial Neural Crest Cells.Tianyuan Shi, Kyosuke Mukae, Maya Shindo
|Nov 13, 2025
Synthetic lethality of EZH2 and DNMT Inhibition suppresses neuroblastoma proliferation via MYCN destabilization.Yuki Endo, Ryuichi P Sugino, Hisanori Takenobu
|Aug 29, 2025
Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project.Mallory R Taylor, James R Anderson, Julie R Park
|Apr 05, 2024
A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.Akihiro Yoneda, Hiroyuki Shichino, Tomoro Hishiki
|Jul 06, 2023
Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project.Kayoko Tao, Fumito Yamazaki, Takashi Kubo
|Jan 20, 2023
Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell-derived neural crest cells.Kyosuke Mukae, Hisanori Takenobu, Yuki Endo
Pageof 2
Frequent Collaborators
6 joint publications
Takehiko Kamijo
4 joint publications
Atsuko Nakazawa
4 joint publications
Kyosuke Mukae
3 joint publications
Tomoro Hishiki
3 joint publications
Yuki Endo
2 joint publications
Jesmin Akter
2 joint publications
Hiroki Nagase
2 joint publications
Kiyohiro Ando
2 joint publications
Hisanori Takenobu
1 joint publications
Etsuko Toda
